Hemant Surgical Industries Limited (BOM:543916)
India · Delayed Price · Currency is INR 156.89
+14.26 (10.00%)
At close: Jul 14, 2025
BOM:543916 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
Operating Revenue | 1,066 | 1,056 | 1,091 | 1,036 | 597.65 | Upgrade |
Other Revenue | 0 | - | - | - | - | Upgrade |
| 1,066 | 1,056 | 1,091 | 1,036 | 597.65 | Upgrade | |
Revenue Growth (YoY) | 0.97% | -3.24% | 5.39% | 73.30% | 6.28% | Upgrade |
Cost of Revenue | 757.04 | 782.48 | 815.55 | 824.29 | 478.69 | Upgrade |
Gross Profit | 309.33 | 273.6 | 275.93 | 211.41 | 118.96 | Upgrade |
Selling, General & Admin | 93.36 | 120.64 | 111.15 | 79.68 | 57.18 | Upgrade |
Other Operating Expenses | 114.56 | 48.25 | 59.08 | 68.74 | 26.51 | Upgrade |
Operating Expenses | 222.18 | 179.15 | 178.73 | 155.91 | 90.03 | Upgrade |
Operating Income | 87.15 | 94.45 | 97.2 | 55.51 | 28.93 | Upgrade |
Interest Expense | -22.04 | -9.45 | -16.87 | -16.08 | -18.01 | Upgrade |
Interest & Investment Income | - | 11.21 | 5.24 | 1.24 | 1.58 | Upgrade |
Currency Exchange Gain (Loss) | - | 13.56 | 14.74 | 4.91 | -4.53 | Upgrade |
Other Non Operating Income (Expenses) | 31.89 | 8.69 | 0.49 | 2.91 | 2.7 | Upgrade |
EBT Excluding Unusual Items | 97 | 118.46 | 100.8 | 48.48 | 10.67 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | -0.23 | - | - | Upgrade |
Other Unusual Items | -11.65 | - | - | - | - | Upgrade |
Pretax Income | 104.66 | 127.81 | 100.57 | 61.12 | 15.2 | Upgrade |
Income Tax Expense | 24.25 | 29.81 | 24.2 | 14.98 | 3.75 | Upgrade |
Net Income | 80.41 | 98 | 76.37 | 46.14 | 11.45 | Upgrade |
Net Income to Common | 80.41 | 98 | 76.37 | 46.14 | 11.45 | Upgrade |
Net Income Growth | -17.95% | 28.32% | 65.52% | 302.86% | 128.42% | Upgrade |
Shares Outstanding (Basic) | 10 | 10 | 7 | 5 | 5 | Upgrade |
Shares Outstanding (Diluted) | 10 | 10 | 7 | 5 | 5 | Upgrade |
Shares Change (YoY) | 4.96% | 33.66% | 44.60% | - | - | Upgrade |
EPS (Basic) | 7.70 | 9.85 | 10.26 | 8.96 | 2.22 | Upgrade |
EPS (Diluted) | 7.70 | 9.85 | 10.26 | 8.96 | 2.22 | Upgrade |
EPS Growth | -21.82% | -4.00% | 14.50% | 303.60% | 128.87% | Upgrade |
Free Cash Flow | -287.33 | -130.8 | 23.69 | 116.41 | -26.59 | Upgrade |
Free Cash Flow Per Share | -27.52 | -13.15 | 3.18 | 22.61 | -5.17 | Upgrade |
Gross Margin | 29.01% | 25.91% | 25.28% | 20.41% | 19.90% | Upgrade |
Operating Margin | 8.17% | 8.94% | 8.91% | 5.36% | 4.84% | Upgrade |
Profit Margin | 7.54% | 9.28% | 7.00% | 4.46% | 1.92% | Upgrade |
Free Cash Flow Margin | -26.95% | -12.38% | 2.17% | 11.24% | -4.45% | Upgrade |
EBITDA | 101.41 | 104.71 | 105.7 | 62.99 | 35.28 | Upgrade |
EBITDA Margin | 9.51% | 9.92% | 9.68% | 6.08% | 5.90% | Upgrade |
D&A For EBITDA | 14.26 | 10.26 | 8.5 | 7.49 | 6.34 | Upgrade |
EBIT | 87.15 | 94.45 | 97.2 | 55.51 | 28.93 | Upgrade |
EBIT Margin | 8.17% | 8.94% | 8.91% | 5.36% | 4.84% | Upgrade |
Effective Tax Rate | 23.17% | 23.33% | 24.06% | 24.51% | 24.67% | Upgrade |
Revenue as Reported | 1,118 | 1,099 | 1,115 | 1,058 | 606.52 | Upgrade |
Advertising Expenses | - | 5.75 | 9.89 | 2.01 | 1.88 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.